Direct Meds vs Trimi
Two GLP-1 desks, one scoreboard. We put Direct Meds and Trimi head-to-head on the published Brief Score — the same six factors, scored the same way.
Direct Meds
FDA warning letter, September 2025 — issued to directmeds.com, Inc. dba DirectMeds. See the FDA's warning letter database.
The verdict
Trimi takes this head-to-head.
Trimi scores 89 to 82 on our six-factor Brief Score — A clean, all-in membership provider that publishes one price on both molecules nationwide and hasn't played the teaser-rate game.
That doesn't make Direct Meds a bad call — it's best for readers who want a needle-free oral or sublingual route on either molecule and an all-inclusive price with no separate membership — and who are comfortable that the figures are company-stated rather than checkout-verified. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Direct Meds | Trimi | |
|---|---|---|
| Brief Score | 82/100 (B−) | 89/100 (B+) |
| Semaglutide | $249/mo sublingual · $297/mo injectable — both billed monthly on a 3-month minimum commitment | $175/mo month-to-month · $99/mo only on a 12-month prepay ($1,188 in one charge) |
| Tirzepatide | $299/mo sublingual · $399/mo injectable — both billed monthly on a 3-month minimum commitment | $235/mo month-to-month · $125/mo only on a 12-month prepay ($1,500 in one charge) |
| Coverage | Not publicly listed | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Yes | Injection only |
| On the tracker | Stableprice stable | Stableprice stable |
Direct Meds: Company-stated rates unchanged this cycle — but we price these off the provider's own listings, not a live-verified checkout, so treat them as indicative.
Trimi: Membership rate held flat this cycle — both molecules disclosed up front, no first-month teaser.
● Not sold on either?
CoreAge Rx tops the whole ranking at 94/100.
One price on both molecules that does not climb as you titrate — but the headline $99 and $149 are annual-plan rates, paid in full up front.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.